etidronate has been researched along with Recrudescence in 24 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Normocalcemic patients with cancer who had been successfully treated for an episode of hypercalcemia were enrolled in a randomized, multisite, double-blind, placebo-controlled trial designed to determine the efficacy of maintenance oral etidronate in preventing the recurrence of moderate to severe hypercalcemia (serum calcium level, greater than 11." | 9.06 | Maintenance etidronate in the prevention of malignancy-associated hypercalcemia. ( Benson, AB; Bockman, RS; Citrin, DL; Greco, FA; Harvey, HA; Rasmussen, P; Schiller, JH; Siris, ES; Stock, JL; Witte, RS, 1987) |
| "In an open prospective study, we evaluated differences between patients with (wRVF group) and without recurrence of vertebral fracture (woRVF group) during cyclical etidronate therapy for osteoporosis." | 7.70 | Recurrence of vertebral fracture with cyclical etidronate therapy in osteoporosis: histomorphometry and X-Ray microanalysis evaluation. ( Alexandre, C; Barou, O; Lafage-Proust, MH; Thomas, T; Vico, L, 1999) |
| "Although etidronate is effective, risedronate offers a shorter duration of therapy, better and longer-lasting remission, significant reductions in pain, and provides additional remission in subjects who exhibited an incomplete response to previous etidronate treatment." | 5.09 | A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. ( Axelrod, DW; Bekker, PJ; Brown, JP; Hoseyni, MS; Miller, PD; Siris, ES, 1999) |
| "Normocalcemic patients with cancer who had been successfully treated for an episode of hypercalcemia were enrolled in a randomized, multisite, double-blind, placebo-controlled trial designed to determine the efficacy of maintenance oral etidronate in preventing the recurrence of moderate to severe hypercalcemia (serum calcium level, greater than 11." | 5.06 | Maintenance etidronate in the prevention of malignancy-associated hypercalcemia. ( Benson, AB; Bockman, RS; Citrin, DL; Greco, FA; Harvey, HA; Rasmussen, P; Schiller, JH; Siris, ES; Stock, JL; Witte, RS, 1987) |
| "In an open prospective study, we evaluated differences between patients with (wRVF group) and without recurrence of vertebral fracture (woRVF group) during cyclical etidronate therapy for osteoporosis." | 3.70 | Recurrence of vertebral fracture with cyclical etidronate therapy in osteoporosis: histomorphometry and X-Ray microanalysis evaluation. ( Alexandre, C; Barou, O; Lafage-Proust, MH; Thomas, T; Vico, L, 1999) |
| " Measurement of urinary excretion of EHDP was used to define the best dosage regimen." | 2.64 | Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate in calcium nephrolithiasis. ( Baumann, JM; Bisaz, S; Fleisch, H; Wacker, M, 1978) |
| "After discontinuation of drug therapy, recurrence was variable but less than expected." | 2.64 | Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. ( Miller, JM; Niemann, KM; Stover, SL, 1976) |
| "Specific treatment of cancer remains essential to prevent TIH relapse." | 2.41 | [Tumor-induced hypercalcemia. Review of bisphosphonate treatment]. ( Lortholary, A, 2001) |
| "A true recurrence at exactly the same site is quite unusual in algodystrophy." | 2.40 | Different patterns of extension and recurrence in algodystrophy. ( Audran, M; Bregeon, C; Legrand, E; Masson, C; Pascaretti, C; Renier, JC, 1998) |
| "Etidronate treatment at 200 mg/day resulted in the improvement of bone metabolism markers and bone scintigraphy findings." | 1.32 | Two cases of monostotic Paget's disease: effects of bisphosphonate. ( Aoki, N; Harada, T; Hoshiro, M; Iwai, H; Miyatake, T; Nishimura, A; Ohno, Y, 2003) |
| "A case is reported of progressive ossifying myositis (fibrodysplasia ossificans progressiva, Münchmeyer's disease) with onset at 16 years of age by a lesion of internal pterygoid with limitation of opening of mouth." | 1.27 | [Permanent constriction of the jaws due to progressive ossifying myositis]. ( Bouvier, R; Delmas, P; Freidel, M; Seguin, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seleznev, AN | 1 |
| Sabilo, ES | 1 |
| Savin, AA | 1 |
| Riabov, AG | 1 |
| Kozlov, SA | 1 |
| Zima, LN | 1 |
| Zmievskoĭ, GN | 1 |
| Conner, GA | 1 |
| Duffy, M | 1 |
| Hemmati, I | 1 |
| Wade, J | 1 |
| Kelsall, J | 1 |
| Baranauskaite, A | 1 |
| Hoshiro, M | 1 |
| Harada, T | 1 |
| Iwai, H | 1 |
| Miyatake, T | 1 |
| Nishimura, A | 1 |
| Ohno, Y | 1 |
| Aoki, N | 1 |
| Kanis, JA | 1 |
| Barton, IP | 1 |
| Johnell, O | 1 |
| Jacobellis, U | 1 |
| Salerno, G | 1 |
| Ruotolo, G | 1 |
| Baumann, JM | 2 |
| Biering-Sørensen, F | 1 |
| Tøndevold, E | 1 |
| Masson, C | 1 |
| Audran, M | 1 |
| Pascaretti, C | 1 |
| Legrand, E | 1 |
| Bregeon, C | 1 |
| Renier, JC | 1 |
| Thomas, T | 1 |
| Barou, O | 1 |
| Vico, L | 1 |
| Alexandre, C | 1 |
| Lafage-Proust, MH | 1 |
| Hosking, DJ | 1 |
| Miller, PD | 1 |
| Brown, JP | 1 |
| Siris, ES | 2 |
| Hoseyni, MS | 1 |
| Axelrod, DW | 1 |
| Bekker, PJ | 1 |
| Banovac, K | 1 |
| Lortholary, A | 1 |
| Bisaz, S | 1 |
| Fleisch, H | 1 |
| Wacker, M | 1 |
| Stover, SL | 1 |
| Niemann, KM | 1 |
| Miller, JM | 1 |
| Ralston, SH | 1 |
| Gallacher, SJ | 1 |
| Patel, U | 1 |
| Dryburgh, FJ | 1 |
| Fraser, WD | 1 |
| Cowan, RA | 1 |
| Boyle, IT | 1 |
| Ahrengart, L | 1 |
| Lindgren, U | 1 |
| Nollen, AJ | 1 |
| Schiller, JH | 1 |
| Rasmussen, P | 1 |
| Benson, AB | 1 |
| Witte, RS | 1 |
| Bockman, RS | 1 |
| Harvey, HA | 1 |
| Citrin, DL | 1 |
| Greco, FA | 1 |
| Stock, JL | 1 |
| Heath, DA | 1 |
| Seguin, P | 1 |
| Delmas, P | 1 |
| Bouvier, R | 1 |
| Freidel, M | 1 |
| Smith, R | 1 |
| Russell, RG | 1 |
| Bishop, MC | 1 |
| Woods, CG | 1 |
| Bishop, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for etidronate and Recrudescence
| Article | Year |
|---|---|
Myositis ossificans: a case report of multiple recurrences following third molar extractions and review of the literature.
Topics: Adolescent; Diagnosis, Differential; Etidronic Acid; Female; Follow-Up Studies; Humans; Masseter Mus | 2009 |
Risedronate-associated scleritis: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Brain; China; Diphosphonates; Etidronic Acid; Female; Humans; Inflamm | 2012 |
[Osteoporosis: diagnosis and treatment of vertebral fractures].
Topics: Age Factors; Aged; Calcium; Calcium Channel Blockers; Etidronic Acid; Female; Humans; Male; Middle A | 2002 |
Different patterns of extension and recurrence in algodystrophy.
Topics: Adult; Bone and Bones; Diagnosis, Differential; Disease Progression; Etidronic Acid; Factitious Diso | 1998 |
Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.
Topics: Alkaline Phosphatase; Bone Resorption; Diphosphonates; Etidronic Acid; Half-Life; Humans; Osteitis D | 1999 |
[Tumor-induced hypercalcemia. Review of bisphosphonate treatment].
Topics: Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Etidronic Acid; Fluid Therapy; Hematolog | 2001 |
Treating Paget's disease.
Topics: Calcitonin; Etidronic Acid; Forecasting; Humans; Osteitis Deformans; Recurrence | 1987 |
7 trials available for etidronate and Recrudescence
| Article | Year |
|---|---|
[Mechanisms of formation of chronic low back pain relapse and their correction in patients with dorsopathy].
Topics: Algorithms; Anxiety; Bone Density Conservation Agents; Chronic Disease; Depression; Disease Progress | 2008 |
Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.
Topics: Absorptiometry, Photon; Aged; Anthropometry; Bone Density; Double-Blind Method; Etidronic Acid; Fema | 2005 |
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Calcium Channel Blockers; Double-B | 1999 |
Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate in calcium nephrolithiasis.
Topics: Adult; Calcium Phosphates; Calcium Pyrophosphate; Clinical Trials as Topic; Drug Administration Sche | 1978 |
Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients.
Topics: Adult; Etidronic Acid; Humans; Myositis Ossificans; Organophosphorus Compounds; Postoperative Care; | 1976 |
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.
Topics: Administration, Oral; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Drug Administration | 1989 |
Maintenance etidronate in the prevention of malignancy-associated hypercalcemia.
Topics: Administration, Oral; Clinical Trials as Topic; Double-Blind Method; Etidronic Acid; Female; Humans; | 1987 |
10 other studies available for etidronate and Recrudescence
| Article | Year |
|---|---|
Two cases of monostotic Paget's disease: effects of bisphosphonate.
Topics: Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Diphosphonates | 2003 |
[The use of 1-alpha-cholecalciferol in subjects treated for a prolonged time with diphosphonates for recurrent calcium nephrolithiasis].
Topics: Cholecalciferol; Drug Therapy, Combination; Etidronic Acid; Humans; Hypophosphatasia; Kidney Calculi | 1984 |
[Inhibitors of crystallization and calcium nephrolithiasis].
Topics: Calcium Oxalate; Chemical Phenomena; Chemistry; Crystallization; Diphosphates; Etidronic Acid; Glyco | 1980 |
Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports.
Topics: Adolescent; Adult; Etidronic Acid; Hip; Humans; Indomethacin; Male; Ossification, Heterotopic; Recur | 1993 |
Recurrence of vertebral fracture with cyclical etidronate therapy in osteoporosis: histomorphometry and X-Ray microanalysis evaluation.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Density; Bone Remodeling; Calcium; Electron Probe Micro | 1999 |
The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
Topics: Administration, Oral; Adolescent; Adult; Etidronic Acid; Female; Follow-Up Studies; Humans; Infusion | 2000 |
Prevention of ectopic bone formation by local application of ethane-1-hydroxy-1,1-diphosphonate (EHDP): an experimental study in rabbits.
Topics: Animals; Bone and Bones; Bone Cements; Bone Neoplasms; Choristoma; Dose-Response Relationship, Drug; | 1986 |
Effects of ethylhydroxydiphosphonate (EHDP) on heterotopic ossification.
Topics: Adult; Aged; Drug Evaluation; Elbow Joint; Etidronic Acid; Female; Follow-Up Studies; Hip Joint; Hum | 1986 |
[Permanent constriction of the jaws due to progressive ossifying myositis].
Topics: Adolescent; Ankylosis; Chronic Disease; Combined Modality Therapy; Diphosphonates; Etidronic Acid; F | 1987 |
Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
Topics: Adult; Aged; Alkaline Phosphatase; Biopsy; Bone Resorption; Calcitonin; Calcium; Clinical Enzyme Tes | 1973 |